Invention Grant
- Patent Title: Bicyclic heterocycles as FGFR inhibitors
-
Application No.: US16566509Application Date: 2019-09-10
-
Publication No.: US10947230B2Publication Date: 2021-03-16
- Inventor: Yaping Sun , Wenqing Yao , Liangxing Wu , Meizhong Xu , Ding-Quan Qian , Fenglei Zhang
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington; US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington; US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00 ; A61K31/4375
Abstract:
The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Public/Granted literature
- US20200095244A1 BICYCLIC HETEROCYCLES AS FGFR INHIBITORS Public/Granted day:2020-03-26
Information query
